J. Ge

发表

Evidence that the atypical 5‐HT3 receptor ligand, [3H]‐BRL46470, labels additional 5‐HT3 binding sites compared to [3H]‐granisetron

T. Blackburn, J. A. Peters, A. Hope, 1995, British journal of pharmacology.

Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo

N. Barnes, D. C. Brown, L. J. Steward, 1996, British journal of pharmacology.

Autoradiographic Mapping of Brain 5-HT2A Binding Sites in P and in AA Alcohol-Preferring Rats

S. Cooper, N. Barnes, R. Ciccocioppo, 1997, Brain Research Bulletin.

Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.

N. Barnes, J. Ge, J. Barnes, 1997, European journal of pharmacology.

Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamine.

R. Naylor, N. Barnes, J. Rudd, 1990, British Journal of Cancer.

Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain

N. Barnes, R. Parker, J. Ge, 1996, Journal of the Neurological Sciences.

Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.

I. Kilpatrick, J. Ge, S. Long, 1998, European journal of pharmacology.

[125I]S(-)-zacopride labels a novel 5-hydroxytryptamine sensitive recognition site in rat duodenum and ileum.

N. Barnes, J. Ge, A. Patel, 1996, European journal of pharmacology.

Inhibition of progesterone receptor membrane component-1 exacerbates neonatal hypoxic-ischemic cerebral damage in male mice

Taiyang Zhu, F. Hua, Jingjing Han, 2021, Experimental Neurology.

Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders.

N. Barnes, J. Ge, 1996, European journal of pharmacology.

The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5‐HT release in the frontal cortex of freely‐moving rats

R. Naylor, J. Ge, C. Cheng, 1993, British journal of pharmacology.

Differential modulation of extracellular levels of 5‐hydroxytryptamine in the rat frontal cortex by (R)‐ and (S)‐zacopride

B. Costall, R. Naylor, N. Barnes, 1992, British journal of pharmacology.

Effect of Aversive Stimulation on 5-Hydroxytryptamine and Dopamine Metabolism in the Rat Brain

B. Costall, R. Naylor, N. Barnes, 1997, Pharmacology Biochemistry and Behavior.

Ability of 5‐HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo

R. Bruton, N. Barnes, P. Stokes, 1996, British journal of pharmacology.

5‐HT4 receptor‐mediated modulation of 5‐HT release in the rat hippocampus in vivo

N. Barnes, J. Ge, 1996, British journal of pharmacology.

Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo.

R. Bruton, N. Barnes, J. Ge, 1999, European journal of pharmacology.